FGFR3 and urinary bladder cancer: Previous works have examined the role of FGFR3 mutations in murine models of bladder cancer and, with the exception of a recent report (19), have consistently demonstrated that FGFR3 mutations alone are not sufficient to promote urothelial tumorigenesis.